Advertisement

Bharat Biotech seeks emergency use authorisation for Covid vaccine Covaxin in India

Hyderabad-based Bharat Biotech has sought emergency use auhtorisation from the Drug Controller General of India (DGCI) for its indigenously made Covid vaccine Covaxin.

After Pfizer and the Serum Institute of India, Bharat Biotech has become the third pharmaceutical in India to seek emergency use authorisation for its Covid vaccine in India.

Read More

VIDEOS FROM OTHER SECTIONS

LATEST VIDEOS

India-US trade deal: Win-win or one-sided deal?

A day after US President Donald Trump on Monday announced the landmark India-US trade deal and that he would reduce reciprocal tariffs from 25 per cent to 18 per cent, a massive political war has erupted in Delhi.

advertisement